Related Experiment Video
Updated: Nov 6, 2025

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
583
Is BASILICA the Standard for Preventing Coronary Obstruction in High-Risk Transcatheter Aortic Valve Replacement?
Ole De Backer1, Lars Søndergaard1
1The Heart Centre, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
JACC. Cardiovascular Interventions
|May 7, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
Aortic Regurgitation III: Medical Management
117
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
117
Coronary Artery Disease V: Interprofessional Care
91
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
91

